New medicine to treat non-muscle invasive bladder cancer

View source ↗

Summary

The EMA announced approval of a new medicine, Anktiva (bempegaldesleukin), for non-muscle invasive bladder cancer that does not respond to Bacillus Calmette-Gué…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Anktiva (N-803)

Snippet

Anktiva provides an alternative to surgery for patients whose cancer does not respond to treatment with Bacillus Calmette-Guérin